Why Take Low-Dose Naltrexone at Night? Timing and Benefits Explained
Most low-dose naltrexone protocols recommend taking it at night — here's the biology behind that timing, and when switching to morning dosing makes sense instead.
Read More
Most low-dose naltrexone protocols recommend taking it at night — here's the biology behind that timing, and when switching to morning dosing makes sense instead.
Read More
Forgetting why you walked into a room isn't always just aging. Here's what actually causes brain fog, and...
Read More
Peptides are having a moment in wellness marketing, but they're really the body's chemical messaging system — here's...
Read More
Sleep is one of the three pillars of health. It affects everything you do and every performance metric....
Read More
Wellness · Natural Pain Relief Pain wears many hats. Whether it comes from weekend warrior stunts in the yard or chronic conditions like arthritis and diabetic...
Read More
Sometimes mebendazole can substitute for ivermectin — for pinworm, roundworm, or hookworm. For strongyloidiasis, scabies, or tissue-resident parasites, it can't. Here's when substitution works and when...
Read More
Women's Health · Oncology Approximately 1 in 8 women in the US (13.1%) will be diagnosed with invasive breast cancer over the course of their lifetime....
Read More
Men's Health · Cancer Awareness Odds are that you or someone you know is dealing with prostate cancer. The explosion of prostate cancer cases in recent...
Read More
Cancer Research · Emerging Therapies A landmark study of 122 cancer patients who self-reported their outcomes after taking a combination of ivermectin and mebendazole proved what...
Read More
Integrative Oncology · Holistic Support 10 Promising Compounds Supporting the Body's Fight Against Cancer As cancer care evolves, more attention is turning to gentler, more holistic...
Read More
Health & Safety Alert The Four Most Dangerous Tick-Borne Diseases — And the One Drug That Treats Them All Tick season is intensifying across the U.S....
Read More
A new observational report from The Wellness Company highlights promising real-world outcomes using ivermectin and mebendazole in cancer patients, with an 84% clinical benefit rate and...
Read More